NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 130 filers reported holding NOVAVAX INC in Q2 2017. The put-call ratio across all filers is 1.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $72,000 | -91.0% | 130,332 | -69.9% | 0.03% | -93.6% |
| Q4 2018 | $796,000 | +17.9% | 432,344 | +20.4% | 0.44% | +128.6% |
| Q3 2018 | $675,000 | +89.1% | 359,194 | +35.1% | 0.19% | +104.3% |
| Q2 2018 | $357,000 | +1522.7% | 265,894 | +2432.3% | 0.09% | +1466.7% |
| Q1 2018 | $22,000 | +69.2% | 10,500 | 0.0% | 0.01% | +100.0% |
| Q4 2017 | $13,000 | +8.3% | 10,500 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $12,000 | -50.0% | 10,500 | -50.0% | 0.00% | 0.0% |
| Q2 2017 | $24,000 | +84.6% | 21,000 | +100.0% | 0.00% | -57.1% |
| Q1 2017 | $13,000 | -40.9% | 10,500 | 0.0% | 0.01% | -50.0% |
| Q3 2016 | $22,000 | -71.1% | 10,500 | 0.0% | 0.01% | -68.2% |
| Q2 2016 | $76,000 | +40.7% | 10,500 | 0.0% | 0.04% | +10.0% |
| Q1 2016 | $54,000 | -38.6% | 10,500 | 0.0% | 0.04% | -36.5% |
| Q4 2015 | $88,000 | – | 10,500 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Caption Management, LLC | 2,021,600 | $22,273,000 | 1.23% |
| GREAT POINT PARTNERS LLC | 4,500,000 | $2,479,000 | 0.24% |
| SABBY MANAGEMENT, LLC | 860,000 | $474,000 | 0.23% |
| Sargent Investment Group, LLC | 588,070 | $324,000 | 0.16% |
| BB BIOTECH AG | 8,330,000 | $4,589,000 | 0.12% |
| GREAT POINT PARTNERS LLC | 2,000,000 | $1,102,000 | 0.11% |
| CENTAURUS FINANCIAL, INC. | 7 | $12,000,000 | 0.07% |
| Rock Springs Capital Management LP | 3,250,000 | $1,790,000 | 0.07% |
| Beirne Wealth Consulting Services, LLC | 155,000 | $85,000 | 0.07% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $138,000 | 0.07% |